# Treatment of Moderate to Severe Facial Acne Vulgaris

> **NCT00612573** · PHASE2 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 257 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Doxycycline 0.6 mg/kg/day
- **DRUG:** Doxycycline 1.2 mg/kg/day
- **DRUG:** Doxycycline 2.4 mg/kg/day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00612573
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612573, "Treatment of Moderate to Severe Facial Acne Vulgaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00612573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*